Resmed (RMD) Change in Receivables (2009 - 2026)

Resmed's Change in Receivables history runs 18 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• Quarterly Change in Receivables fell 57.89% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.8 million (down 49.78% YoY) and the FY2025 annual result came in at $76.7 million, down 42.89% from the prior year.
• Change in Receivables was $16.9 million for Q1 2026 at Resmed, down from $72.7 million in the prior quarter.
• Across five years, Change in Receivables topped out at $78.8 million in Q2 2022 and bottomed at -$36.4 million in Q3 2024.
• A 5-year average of $25.9 million and a median of $19.6 million in 2022 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 347.27% in 2024, while the deepest fall reached 457.35% in 2024.
• Resmed's Change in Receivables stood at $19.6 million in 2022, then soared by 36.85% to $26.8 million in 2023, then surged by 153.15% to $67.9 million in 2024, then increased by 7.12% to $72.7 million in 2025, then sank by 76.81% to $16.9 million in 2026.
• Business Quant data shows RMD's Change in Receivables at $16.9 million in Q1 2026, $72.7 million in Q4 2025, and -$30.0 million in Q3 2025.